Office of the Registrar or Lobbying of BC

Menus

  • Menus

www.lobbyistsregistrar.bc.ca

  • www.lobbyistsregistrar.bc.ca

Designated Filer menu

  • Registry Search Tools
    • 12-Month Lobbying Activity Search
    • Advanced Registry Search
  • Reporting Tools
    • Recent Registrations
    • Recent Lobbying Activity Reports by Posted Date
    • Government Funding Report
    • Gifts to Public Office Holders Report
    • Listing of All Lobbyists and Senior Officers
    • Listing of Senior Public Officer Holders who are in Lobbying Activity Reports
    • Listing of Organizations Clients and their Direct Interests
  • Lobbying Statistics
    • Active Lobbyists and Registrations by Type
    • Ministries/Provincial Entities in Active Registrations
    • Ministries/Provincial Entities in Lobbying Activity Reports
    • Lobbying Activity Reports by Reporting Period
    • Subject Matter in Active Registrations
    • Subject Matter in Lobbying Activity Reports
    • Intended Outcomes in Active Registrations
    • Intended Outcomes in Lobbying Activity Reports
  • Help
    • LTA Guidance Documents
    • Using the Registry
    • Legislation
    • LTA Frequently Asked Questions
    • Contact Us
  • Sign In

You are here:

  1. Registry Dashboard

 

Subject matter details

Cystic Fibrosis Canada


Registration: 21 of 21 (2026-11-05 to present)

Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Access to high-quality CF care. Advocate for policies, programs and investments that support timely, equitable access to specialized, coordinated and high-quality cystic fibrosis care throughout British Columbia.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Access to medicines, treatments and health technologies. Advocate for timely, equitable and affordable access to medicines, treatments and other health technologies for people with cystic fibrosis, including current and emerging therapies.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Diagnosis, testing, data and health-system improvement. Advocate for policies, programs and investments that improve the diagnosis and management of cystic fibrosis, including access to screening and genetic testing, health data and patient registries, and evidence-informed health-system planning.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health